Topical BRAF inhibitor relieves EGFR-induced acneiform eruption
07 Jul 2025
byAudrey Abella
LUT014 gel, a novel, small-molecule, topical formulation of a BRAF inhibitor, relieves acneiform rash toxicities from anti-EGFR therapies, findings from a phase II study suggest.